Sanofi OTCMKTS: SNYNF has filed 13-F forms with the SEC as an investor. Sanofi is itself a publicly traded company. Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. For more information on Sanofi stock, visit the Sanofi stock profile here.
Investment Activity
- Sanofi has $335.96 million in total holdings as of March 31, 2026.
- Sanofi owns shares of 9 different stocks, but just 4 companies or ETFs make up 80% of its holdings.
- Approximately 8.69% of the portfolio was purchased this quarter.
- This quarter, Sanofi has purchased 8 new stocks and bought additional shares in 0 stocks.
- Sanofi sold shares of 0 stocks and completely divested from 0 stocks this quarter.
Largest Holdings
- Inhibrx Biosciences, Inc.
- $77,847,365
- Agomab Therapeutics NV
- $29,194,677
Largest New Holdings this Quarter
- 00860C102 - Agomab Therapeutics NV
- $29,194,677 Holding
Largest Purchases this Quarter
- Agomab Therapeutics NV
- 2,783,096 shares (about $29.19M)
